Annual Cash & Cash Equivalents
$362.91 M
+$208.41 M+134.90%
31 March 2024
Summary:
Taro Pharmaceutical Industries annual cash & cash equivalents is currently $362.91 million, with the most recent change of +$208.41 million (+134.90%) on 31 March 2024. During the last 3 years, it has fallen by -$242.27 million (-40.03%).TARO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$362.91 M
-$19.50 M-5.10%
31 March 2024
Summary:
Taro Pharmaceutical Industries quarterly cash and cash equivalents is currently $362.91 million, with the most recent change of -$19.50 million (-5.10%) on 31 March 2024. Over the past year, it has increased by +$93.90 million (+34.90%).TARO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +134.9% | +34.9% |
| 3 y3 years | -40.0% | -30.7% |
| 5 y5 years | -36.0% | -35.3% |
TARO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -40.0% | -56.0% |
Taro Pharmaceutical Industries Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $362.91 M(+134.9%) | $362.91 M(-5.1%) |
| Dec 2023 | - | $382.41 M(+42.2%) |
| Sept 2023 | - | $269.01 M(+116.7%) |
| June 2023 | - | $124.17 M(-19.6%) |
| Mar 2023 | $154.50 M(-38.5%) | $154.50 M(-11.8%) |
| Sept 2022 | - | $175.19 M(-22.4%) |
| June 2022 | - | $225.80 M(-10.1%) |
| Mar 2022 | $251.13 M(-58.5%) | $251.13 M(-21.1%) |
| Dec 2021 | - | $318.10 M(-39.3%) |
| Sept 2021 | - | $523.67 M(-14.8%) |
| June 2021 | - | $614.89 M(+1.6%) |
| Mar 2021 | $605.18 M(+17.9%) | $605.18 M(+9.5%) |
| Dec 2020 | - | $552.92 M(+10.9%) |
| Sept 2020 | - | $498.80 M(-6.2%) |
| June 2020 | - | $532.04 M(+3.6%) |
| Mar 2020 | $513.35 M(-9.5%) | $513.35 M(+0.8%) |
| Dec 2019 | - | $509.36 M(-9.2%) |
| Sept 2019 | - | $560.67 M(-11.4%) |
| June 2019 | - | $632.99 M(+11.5%) |
| Mar 2019 | $567.45 M(-1.6%) | $567.45 M(+0.2%) |
| Dec 2018 | - | $566.47 M(-31.4%) |
| Sept 2018 | - | $825.60 M(+28.6%) |
| June 2018 | - | $641.99 M(+11.3%) |
| Mar 2018 | $576.61 M(-4.0%) | $576.61 M(+1.3%) |
| Dec 2017 | - | $569.19 M(+13.1%) |
| Sept 2017 | - | $503.32 M(+16.9%) |
| June 2017 | - | $430.71 M(-28.3%) |
| Mar 2017 | $600.40 M(+4.1%) | $600.40 M(+9.2%) |
| Dec 2016 | - | $549.65 M(+50.3%) |
| Sept 2016 | - | $365.64 M(-16.7%) |
| June 2016 | - | $438.73 M(-23.9%) |
| Mar 2016 | $576.76 M(+19.7%) | $576.76 M(+10.2%) |
| Dec 2015 | - | $523.21 M(+7.3%) |
| Sept 2015 | - | $487.69 M(+11.1%) |
| June 2015 | - | $439.00 M(-8.9%) |
| Mar 2015 | $481.64 M(+129.4%) | $481.64 M(+70.1%) |
| Dec 2014 | - | $283.22 M(+9.5%) |
| Sept 2014 | - | $258.62 M(-18.6%) |
| June 2014 | - | $317.87 M(+51.4%) |
| Mar 2014 | $209.97 M(-11.5%) | $209.97 M(+1.2%) |
| Dec 2013 | - | $207.46 M(-40.8%) |
| Sept 2013 | - | $350.61 M(+28.2%) |
| June 2013 | - | $273.56 M(+15.3%) |
| Mar 2013 | $237.28 M(-0.4%) | $237.28 M(-14.3%) |
| Dec 2012 | - | $277.00 M(-32.2%) |
| Sept 2012 | - | $408.70 M(+19.3%) |
| June 2012 | - | $342.56 M(+10.3%) |
| Mar 2012 | $238.27 M(-0.6%) | $310.71 M(+29.6%) |
| Dec 2011 | $239.81 M(+181.7%) | $239.81 M(+16.3%) |
| Sept 2011 | - | $206.15 M(+38.0%) |
| June 2011 | - | $149.34 M(+24.5%) |
| Mar 2011 | - | $119.98 M(+40.9%) |
| Dec 2010 | $85.14 M(-8.7%) | $85.14 M(-4.8%) |
| Sept 2010 | - | $89.48 M(+3.7%) |
| June 2010 | - | $86.31 M(-7.5%) |
| Dec 2009 | $93.31 M | $93.31 M(+14.2%) |
| Sept 2009 | - | $81.70 M(+12.1%) |
| June 2009 | - | $72.86 M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $80.75 M(+17.3%) |
| Dec 2008 | $68.83 M(+52.3%) | $68.83 M(+3.9%) |
| Sept 2008 | - | $66.25 M(-9.0%) |
| Dec 2007 | $45.19 M(+180.0%) | - |
| Dec 2006 | $16.14 M(-77.8%) | - |
| Dec 2005 | $72.83 M(-26.2%) | $72.83 M(-5.1%) |
| Sept 2005 | - | $76.74 M(-2.4%) |
| June 2005 | - | $78.67 M(+0.8%) |
| Mar 2005 | - | $78.01 M(-20.9%) |
| Dec 2004 | $98.63 M(-38.0%) | $98.63 M(+8.2%) |
| Sept 2004 | - | $91.19 M(-3.2%) |
| June 2004 | - | $94.16 M(-11.5%) |
| Mar 2004 | - | $106.36 M(-33.2%) |
| Dec 2003 | $159.12 M(+21.7%) | $159.12 M(+16.3%) |
| Sept 2003 | - | $136.86 M(-10.4%) |
| June 2003 | - | $152.78 M(+25.4%) |
| Mar 2003 | - | $121.86 M(-6.8%) |
| Dec 2002 | $130.72 M(-14.6%) | $130.72 M(-3.3%) |
| Sept 2002 | - | $135.13 M(+1.2%) |
| June 2002 | - | $133.48 M(-7.1%) |
| Mar 2002 | - | $143.73 M(-6.1%) |
| Dec 2001 | $153.15 M(+2013.8%) | $153.15 M(+865.0%) |
| Sept 2001 | - | $15.87 M(+410.6%) |
| June 2001 | - | $3.11 M(+74.7%) |
| Mar 2001 | - | $1.78 M(-75.4%) |
| Dec 2000 | $7.25 M(+141.3%) | $7.25 M(+470.0%) |
| Sept 2000 | - | $1.27 M(-52.5%) |
| June 2000 | - | $2.68 M(+27.4%) |
| Mar 2000 | - | $2.10 M(-30.1%) |
| Dec 1999 | $3.00 M(+173.0%) | $3.00 M(+233.7%) |
| Sept 1999 | - | $900.00 K(+28.6%) |
| June 1999 | - | $700.00 K(-12.5%) |
| Mar 1999 | - | $800.00 K(-27.3%) |
| Dec 1998 | $1.10 M(+37.5%) | $1.10 M(-57.7%) |
| Mar 1998 | - | $2.60 M(+225.0%) |
| Dec 1997 | $800.00 K(+33.3%) | $800.00 K(-68.0%) |
| Sept 1997 | - | $2.50 M(0.0%) |
| June 1997 | - | $2.50 M(-7.4%) |
| Mar 1997 | - | $2.70 M(+350.0%) |
| Dec 1996 | $600.00 K(-25.0%) | $600.00 K(-76.9%) |
| Sept 1996 | - | $2.60 M(+8.3%) |
| June 1996 | - | $2.40 M(-4.0%) |
| Mar 1996 | - | $2.50 M(+212.5%) |
| Dec 1995 | $800.00 K(-38.5%) | $800.00 K(-38.5%) |
| Dec 1994 | $1.30 M(0.0%) | $1.30 M(0.0%) |
| Dec 1993 | $1.30 M(+550.0%) | $1.30 M(+550.0%) |
| Dec 1992 | $200.00 K(-66.7%) | $200.00 K(-96.2%) |
| Sept 1992 | - | $5.30 M(+783.3%) |
| June 1992 | - | $600.00 K(-62.5%) |
| Mar 1992 | - | $1.60 M(+166.7%) |
| Dec 1991 | $600.00 K(+100.0%) | $600.00 K(+50.0%) |
| Sept 1991 | - | $400.00 K(+33.3%) |
| June 1991 | - | $300.00 K(-25.0%) |
| Mar 1991 | - | $400.00 K(+33.3%) |
| Dec 1990 | $300.00 K(-57.1%) | $300.00 K(0.0%) |
| Mar 1990 | - | $300.00 K(-57.1%) |
| Dec 1989 | $700.00 K(+600.0%) | $700.00 K(+600.0%) |
| Dec 1988 | $100.00 K(-88.9%) | $100.00 K(-88.9%) |
| Dec 1987 | $900.00 K | $900.00 K |
FAQ
- What is Taro Pharmaceutical Industries annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual cash & cash equivalents year-on-year change?
- What is Taro Pharmaceutical Industries quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly cash and cash equivalents year-on-year change?
What is Taro Pharmaceutical Industries annual cash & cash equivalents?
The current annual cash & cash equivalents of TARO is $362.91 M
What is the all time high annual cash & cash equivalents for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual cash & cash equivalents is $605.18 M
What is Taro Pharmaceutical Industries annual cash & cash equivalents year-on-year change?
Over the past year, TARO annual cash & cash equivalents has changed by +$208.41 M (+134.90%)
What is Taro Pharmaceutical Industries quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TARO is $362.91 M
What is the all time high quarterly cash and cash equivalents for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly cash and cash equivalents is $825.60 M
What is Taro Pharmaceutical Industries quarterly cash and cash equivalents year-on-year change?
Over the past year, TARO quarterly cash and cash equivalents has changed by +$93.90 M (+34.90%)